22.05.2022 Views

DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

1078 (IRP1 and IRP2). Double knockout of the genes encoding these proteins

is embryonic lethal, and conditional double knockout of these

genes in the intestine results in cellular iron depletion and death of

intestinal epithelial cells (Galy et al., 2008). These IRPs are cytosolic

RNA-binding proteins that bind to iron regulating elements

(IREs) present in the 5′ or 3′ untranslated regions of mRNA encoding

apoferritin or the transferrin receptors, respectively. Binding of

these IRPs to the 5′ IRE of apoferritin mRNA represses translation,

whereas binding to the 3′ IRE of mRNA encoding the transferrin

receptors enhances transcript stability, thereby increasing protein

production. When iron is abundant, IRP2 undergoes rapid proteolysis

and IRP1 is converted from a RNA-binding protein into aconitase,

an enzyme that catalyzes the interconversion of citrate and

isocitrate. This results in increased production of apoferritin and

reduced production of transferrin receptors. Conversely, when iron

is in short supply, these IRPs accumulate, thereby repressing

translation of apoferritin while enhancing production of transferrin

receptors.

SECTION IV

INFLAMMATION. IMMUNOMODULATION, AND HEMATOPOIESIS

The flow of iron through the plasma amounts to

a total of 30-40 mg per day in the adult (~0.46 mg/kg

of body weight) (Finch and Huebers, 1982). The major

internal circulation of iron involves the erythron and

reticuloendothelial cells (Figure 37–3). About 80% of

the iron in plasma goes to the erythroid marrow to be

packaged into new erythrocytes; these normally circulate

for ~120 days before being catabolized by the reticuloendothelial

system. At that time, a portion of the iron

is immediately returned to the plasma bound to transferrin

while another portion is incorporated into the ferritin

stores of reticuloendothelial cells and returned to

the circulation more gradually. Isotopic studies indicate

some degree of iron wastage in this process, in which

defective cells or unused portions of their iron are transferred

to the reticuloendothelial cell during maturation,

bypassing the circulating blood. With abnormalities in

erythrocyte maturation, the predominant portion of iron

assimilated by the erythroid marrow may be rapidly

localized in the reticuloendothelial cells as defective

red-cell precursors are broken down; this is termed ineffective

erythropoiesis. The rate of iron turnover in

plasma may be reduced by half or more with red-cell

aplasia, with all the iron directed to the hepatocytes for

storage.

The most remarkable feature of iron metabolism

is the degree to which body stores are conserved. Only

10% of the total is lost per year by normal men (i.e.,

~1 mg/day). Two-thirds of this iron is excreted from the

gastrointestinal (GI) tract as extravasated red cells, iron

in bile, and iron in exfoliated mucosal cells. The other

third is accounted for by small amounts of iron in

desquamated skin and in the urine. Physiological losses

of iron in men vary over a narrow range, from 0.5 mg

ERYTHROID MARROW

uptake about 25 mg/day

CIRCULATING

ERYTHROCYTES

pool about 2,100 mg;

daily turnover 18 mg

DIETARY IRON

14.4 mg/day;

about 6 mg/1,000 kcal

INTESTINAL MUCOSA

absorption about 1 mg/day

PLASMA IRON

pool about 3 mg;

turnover about 10X/day

INTERSTITIAL

FLUID

PARENCHYMAL

EXCHANGE-

ESPECIALLY LIVER

about 6 mg/day

FERRITIN STORES

RETICULOENDOTHELIUM

25 mg/day from erythron

Figure 37–3. Pathways of iron metabolism in humans (excretion

omitted).

in the iron-deficient individual to 1.5-2 mg per day

when excessive iron is consumed. Additional losses of

iron occur in women due to menstruation. Although the

average loss in menstruating women is ~0.5 mg per day,

10% of menstruating women lose >2 mg per day.

Pregnancy and lactation impose an even greater requirement

for iron (Table 37–3). Other causes of iron loss

include blood donation, the use of anti-inflammatory

drugs that cause bleeding from the gastric mucosa, and

GI disease with associated bleeding. Two much rarer

causes are the hemosiderinuria that follows intravascular

hemolysis, and pulmonary siderosis, where iron

deposited in the lungs becomes unavailable to the rest

of the body.

The limited physiological losses of iron point to

the primary importance of absorption in determining the

body’s iron content (Garrick and Garrick, 2009). After

acidification and partial digestion of food in the stomach,

iron is presented to the intestinal mucosa as either

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!